FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317070791> ?p ?o ?g. }

• W2317070791 endingPage "344" @default.
• W2317070791 startingPage "339" @default.
• W2317070791 abstract "Thirty-one [31] patients with local recurrent or residual adenocarcinoma of the prostate, with no evidence of distant metastases, were treated with second permanent implant using a stereotactic three dimensional system and posterior pararectal CT-guided method. All patients had extensive under local anesthesia or IV sedation pararectal CT-guided biopsy of the prostate and seminal vesicles. All patients except one had 3 month neoadjuvant androgen ablation prior to salvage reimplantation. Twenty [20] of these patients had local recurrence in the prostate and eleven [11] patients had seminal vesicle invasion which was not diagnosed nor treated with the initial brachytherapy. In addition, the patients had PSA failure or local palpable disease, “cold spots” with CT imaging or areas of dosage less than 80% of the prescribed dose with DVH (dose volume histogram). Initial prescribed dose was 120 Gy with 103 Pd loose seeds in 26 patients and 144 Gy with 125 I loose seeds in 5 patients. For the reimplant the dosage in the recurrent site was 100–144 Gy with 125 I seeds in strand in 24 patients (77%) and 100–120 Gy with 103 Pd loose seeds in 7 patients (23%). The preference of 125 I seeds in the second treatment was because only 125 I in strand was available at the time of the reimplant. Eleven [11] patients had second implant twelve to twenty-four months after the initial implant and 20 patients had after twenty-five to eighty-seven months and median follow-up was thirty months. A high level of biochemical control (87%) was achieved in all of these patients who are recognized as high risk due to local recurrence. Four [4] patients experienced grade 2 or 3 GI or GU complications and two [2] patients experienced grade 4 GI complications. Patients with local recurrent prostate cancer following initial brachytherapy including those with seminal vesicle invasion can be successfully treated with pararectal stereotactic CT-guided reimplantation. Assessment of seminal vesicle status is an essential part of staging for local recurrence." @default.
• W2317070791 created "2016-06-24" @default.
• W2317070791 creator A5006454224 @default.
• W2317070791 creator A5008326095 @default.
• W2317070791 creator A5008757884 @default.
• W2317070791 creator A5017063294 @default.
• W2317070791 creator A5032309850 @default.
• W2317070791 creator A5032844615 @default.
• W2317070791 creator A5045042752 @default.
• W2317070791 creator A5085324139 @default.
• W2317070791 date "2003-08-01" @default.
• W2317070791 modified "2023-10-12" @default.
• W2317070791 title "Salvage Reimplantation in Patient with Local Recurrent Prostate Carcinoma after Brachytherapy with Three Dimensional Computed Tomography-Guided Permanent Pararectal Implant" @default.
• W2317070791 cites W1966721434 @default.
• W2317070791 cites W1971949046 @default.
• W2317070791 cites W1978220198 @default.
• W2317070791 cites W1990474676 @default.
• W2317070791 cites W2009415166 @default.
• W2317070791 cites W2014320016 @default.
• W2317070791 cites W2055976120 @default.
• W2317070791 cites W2066197900 @default.
• W2317070791 cites W2124068199 @default.
• W2317070791 cites W2126645707 @default.
• W2317070791 cites W2131173558 @default.
• W2317070791 cites W2142707057 @default.
• W2317070791 cites W2148050247 @default.
• W2317070791 cites W2329106677 @default.
• W2317070791 cites W4293241248 @default.
• W2317070791 cites W4301341292 @default.
• W2317070791 cites W72800367 @default.
• W2317070791 doi "https://doi.org/10.1177/153303460300200409" @default.
• W2317070791 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12892517" @default.
• W2317070791 hasPublicationYear "2003" @default.
• W2317070791 type Work @default.
• W2317070791 sameAs 2317070791 @default.
• W2317070791 citedByCount "44" @default.
• W2317070791 countsByYear W23170707912012 @default.
• W2317070791 countsByYear W23170707912013 @default.
• W2317070791 countsByYear W23170707912014 @default.
• W2317070791 countsByYear W23170707912015 @default.
• W2317070791 countsByYear W23170707912016 @default.
• W2317070791 countsByYear W23170707912017 @default.
• W2317070791 countsByYear W23170707912018 @default.
• W2317070791 countsByYear W23170707912019 @default.
• W2317070791 countsByYear W23170707912020 @default.
• W2317070791 countsByYear W23170707912021 @default.
• W2317070791 countsByYear W23170707912023 @default.
• W2317070791 crossrefType "journal-article" @default.
• W2317070791 hasAuthorship W2317070791A5006454224 @default.
• W2317070791 hasAuthorship W2317070791A5008326095 @default.
• W2317070791 hasAuthorship W2317070791A5008757884 @default.
• W2317070791 hasAuthorship W2317070791A5017063294 @default.
• W2317070791 hasAuthorship W2317070791A5032309850 @default.
• W2317070791 hasAuthorship W2317070791A5032844615 @default.
• W2317070791 hasAuthorship W2317070791A5045042752 @default.
• W2317070791 hasAuthorship W2317070791A5085324139 @default.
• W2317070791 hasConcept C121608353 @default.
• W2317070791 hasConcept C126322002 @default.
• W2317070791 hasConcept C126838900 @default.
• W2317070791 hasConcept C126894567 @default.
• W2317070791 hasConcept C141071460 @default.
• W2317070791 hasConcept C2775908122 @default.
• W2317070791 hasConcept C2775934546 @default.
• W2317070791 hasConcept C2776235491 @default.
• W2317070791 hasConcept C2776694085 @default.
• W2317070791 hasConcept C2776742690 @default.
• W2317070791 hasConcept C2777416452 @default.
• W2317070791 hasConcept C2780775027 @default.
• W2317070791 hasConcept C2781411149 @default.
• W2317070791 hasConcept C2989005 @default.
• W2317070791 hasConcept C509974204 @default.
• W2317070791 hasConcept C71924100 @default.
• W2317070791 hasConceptScore W2317070791C121608353 @default.
• W2317070791 hasConceptScore W2317070791C126322002 @default.
• W2317070791 hasConceptScore W2317070791C126838900 @default.
• W2317070791 hasConceptScore W2317070791C126894567 @default.
• W2317070791 hasConceptScore W2317070791C141071460 @default.
• W2317070791 hasConceptScore W2317070791C2775908122 @default.
• W2317070791 hasConceptScore W2317070791C2775934546 @default.
• W2317070791 hasConceptScore W2317070791C2776235491 @default.
• W2317070791 hasConceptScore W2317070791C2776694085 @default.
• W2317070791 hasConceptScore W2317070791C2776742690 @default.
• W2317070791 hasConceptScore W2317070791C2777416452 @default.
• W2317070791 hasConceptScore W2317070791C2780775027 @default.
• W2317070791 hasConceptScore W2317070791C2781411149 @default.
• W2317070791 hasConceptScore W2317070791C2989005 @default.
• W2317070791 hasConceptScore W2317070791C509974204 @default.
• W2317070791 hasConceptScore W2317070791C71924100 @default.
• W2317070791 hasIssue "4" @default.
• W2317070791 hasLocation W23170707911 @default.
• W2317070791 hasLocation W23170707912 @default.
• W2317070791 hasOpenAccess W2317070791 @default.
• W2317070791 hasPrimaryLocation W23170707911 @default.
• W2317070791 hasRelatedWork W2003364719 @default.
• W2317070791 hasRelatedWork W2039186761 @default.
• W2317070791 hasRelatedWork W2071879586 @default.
• W2317070791 hasRelatedWork W2120703505 @default.
• W2317070791 hasRelatedWork W2123312949 @default.

• next